540
Participants
Start Date
December 19, 2019
Primary Completion Date
October 7, 2022
Study Completion Date
October 7, 2022
CS1001+ Fluorouracil+Cisplatin
"CS1001 1200 mg, intravenous infusion on the first day of each cycle (3 weeks) (Q3W).~Fluorouracil: 800 mg/m2/day, continuous intravenous infusion on Day 1 to Day 4 of each cycle Cisplatin: 80 mg/m2, intravenous infusion on the first day of each cycle."
Placebo+ Fluorouracil+Cisplatin
"Placebo 1200 mg, intravenous infusion on the first day of each cycle (3 weeks) (Q3W).~Fluorouracil: 800 mg/m2/day, continuous intravenous infusion on Day 1 to Day 4 of each cycle Cisplatin: 80 mg/m2, intravenous infusion on the first day of each cycle."
Shanghai East Hospital, Shanghai
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Anhui Provincial Hospital, Hefei
Hefei Second People's Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University, Hefei
The Second Affiliated Hospital of Anhui Medical University, Hefei
Beijing Friendship Hospital, Capital Medical University, Beijing
Beijing Tsinghua Changgung Hospital, Beijing
Peaking University International Hospital, Beijing
Chongqing General Hospital, Chongqing
Special Medical Center of The People's Liberation Army of China, Chongqing
The First Affiliated Hospital of Chongqing Medical University, Chongqing
Fujian Cancer Hospital, Fuzhou
The First Affiliated Hospital of Xiamen University, Xiamen
The First People's Hospital of Foshan, Foshan
Cancer Center of Guangzhou Medical University, Guangzhou
Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou
Guangdong Provincial People's Hospital, Guangzhou
Jiangmen Central Hospital, Jiangmen
Jieyang People's Hospital, Jieyang
Affiliated Tumor Hospital of Shantou University Medical College, Shantou
The Fifth Affiliated Hospital of Sun Yat sen University, Zhuhai
Guangxi Medical University Affiliated Tumor Hospital, Nanning
Hainan General Hospital, Haikou
The Second Affiliated Hospital of Hainan Medical University, Haikou
Affiliated Hospital of Chengde Medical University, Chengde
Handan Central Hospital, Handan
Shijiazhuang People's Hospital, Shijiazhuang
The Affiliated Tumor Hospital of Harbin Meidical University, Haerbin
Anyang Cancer Hospital, Anyang
The First Affiliated Hospital of Henan University of Science and Technology, Luoyang
Nanyang Central Hospital, Nanyang
Nanyang First People's Hospital, Nanyang
Puyang Oilfield General Hospital, Puyang
Xinxiang First People's Hospital, Xinxiang
Henan Cancer Hospital, Zhengzhou
Henan Provincial People's Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Hubei Cancer Hospital, Wuhan
Tongji Medical College of HUST, Tongji Medical College Huazhong University of Science and Technology, Wuhan
Wuhan Fifth Hospital, Wuhan
Wuhan Union Hospital, Wuhan
Hunan Cancer Hospital, Changsha
Changzhou Tumor Hospital, Changzhou
Huai'an First People's Hospital, Huai'an
Jiangsu Province Hospital, Nanjing
Jiangxi Cancer Hospital, Nanchang
The First Affiliated Hospital Of Nanchang University, Nanchang
Jilin Cancer Hospital, Changchun
The Second Hospital of Jilin University, Changchun
Tonghua Central Hospital, Tonghua
Liaoning Cancer Hospital and Institute, Shenyang
Jinan central Hospital, Jinan
Shandong Cancer Hospital, Jinan
Linyi Cancer Hospital, Linyi
The Affiliated Hospital of Qingdao University, Qingdao
Shanghai Chest Hospital, Shanghai
Linfen Central Hospital, Linfen
Shanxi Provincial Cancer Hospital, Taiyuan
Chengdu Fifith people's hospital, Chengdu
Sichuan Provincial People's Hospital, Chengdu
West China Hospital Sichuan University, Chengdu
The Affiliated Hospital of Southwest Medical University, Luzhou
Suining Central Hospital, Suining
Yibin Second People's Hospital, Yibin
Tianjin Cancer Hospital, Tianjin
Tianjin Medical University General Hospital, Tianjin
Cancer Hospital Affiliated to Xinjiang Medical University, Ürümqi
Yunnan Cancer Hospital, Kunming
The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou
Zhejiang Cancer Hospital, Hangzhou
Zhejiang Provincial People's Hospital, Hangzhou
Lead Sponsor
CStone Pharmaceuticals
INDUSTRY